Literature DB >> 17116491

Recurrent genomic imbalances in primary effusion lymphomas.

Prakash Nair1, Hongyi Pan, Raymond L Stallings, Shou-Jiang Gao.   

Abstract

Primary effusion lymphomas (PEL) form a subset of AIDS-related lymphomas and usually have a poor prognosis. Although Kaposi's sarcoma-associated herpes virus (KSHV) is often associated with PEL, very little is known about the exact mechanisms or causative effects of these associations. We investigated the chromosomal imbalances in six KSHV-positive PEL cell lines using comparative genomic hybridization analysis. We defined the shortest regions of overlaps for genomic gains on six chromosomes: 1q31, 4q31 approximately q33, 7q10 approximately q21, 8q21.1, 12q0 approximately q23, and Xp11 approximately q21. The recurrent nature of the gains found in these chromosomal regions suggests that these imbalances play roles in the pathogenesis of PEL.

Entities:  

Mesh:

Year:  2006        PMID: 17116491      PMCID: PMC2799290          DOI: 10.1016/j.cancergencyto.2006.07.003

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  12 in total

Review 1.  The role of Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) in lymphoproliferative diseases.

Authors:  Ethel Cesarman
Journal:  Recent Results Cancer Res       Date:  2002

2.  Comparative genomic analyses of primary effusion lymphoma.

Authors:  B P Mullaney; V L Ng; B G Herndier; M S McGrath; M G Pallavicini
Journal:  Arch Pathol Lab Med       Date:  2000-06       Impact factor: 5.534

3.  The human herpes virus 8-encoded viral FLICE inhibitory protein protects against growth factor withdrawal-induced apoptosis via NF-kappa B activation.

Authors:  Qinmiao Sun; Hittu Matta; Preet M Chaudhary
Journal:  Blood       Date:  2002-10-24       Impact factor: 22.113

4.  Molecular characterization of HHV-8 positive primary effusion lymphoma reveals pathogenetic and histogenetic features of the disease.

Authors:  G Gaidano; D Capello; L Fassone; A Gloghini; A M Cilia; C Ariatti; D Buonaiuto; D Vivenza; M Gallicchio; G C Avanzi; M Prat; A Carbone
Journal:  J Clin Virol       Date:  2000-05       Impact factor: 3.168

5.  Chromosomal and comparative genomic analyses of HHV-8-negative primary effusion lymphoma in five HIV-negative Japanese patients.

Authors:  Koichi Ohshima; Masako Ishiguro; Satoshi Yamasaki; Junichi Miyagi; Seichi Okamura; Yasuhiro Sugio; Tsutomu Muta; Hidenori Sasaki; Takeshi Tuchiya; Chika Kawasaki; Masahiro Kikuchi
Journal:  Leuk Lymphoma       Date:  2002-03

Review 6.  A clinical, molecular and cytogenetic study of 12 cases of human herpesvirus 8 associated primary effusion lymphoma in HIV-infected patients.

Authors:  E Boulanger; F Agbalika; O Maarek; M T Daniel; L Grollet; J M Molina; F Sigaux; E Oksenhendler
Journal:  Hematol J       Date:  2001

7.  Molecular polymorphism of Kaposi's sarcoma-associated herpesvirus (Human herpesvirus 8) latent nuclear antigen: evidence for a large repertoire of viral genotypes and dual infection with different viral genotypes.

Authors:  S J Gao; Y J Zhang; J H Deng; C S Rabkin; O Flore; H B Jenson
Journal:  J Infect Dis       Date:  1999-11       Impact factor: 5.226

8.  Analysis of chromosome breakpoints in neuroblastoma at sub-kilobase resolution using fine-tiling oligonucleotide array CGH.

Authors:  Rebecca R Selzer; Todd A Richmond; Nathan J Pofahl; Roland D Green; Peggy S Eis; Prakash Nair; Arthur R Brothman; Raymond L Stallings
Journal:  Genes Chromosomes Cancer       Date:  2005-11       Impact factor: 5.006

9.  Failure to eradicate AIDS-associated primary effusion lymphoma with high-dose chemotherapy and autologous stem cell reinfusion: case report and literature review.

Authors:  Tom W Waddington; David M Aboulafia
Journal:  AIDS Patient Care STDS       Date:  2004-02       Impact factor: 5.078

10.  KSHV vFLIP is essential for the survival of infected lymphoma cells.

Authors:  Ilaria Guasparri; Shannon A Keller; Ethel Cesarman
Journal:  J Exp Med       Date:  2004-04-05       Impact factor: 14.307

View more
  7 in total

1.  A protein array screen for Kaposi's sarcoma-associated herpesvirus LANA interactors links LANA to TIP60, PP2A activity, and telomere shortening.

Authors:  Meir Shamay; Jianyong Liu; Renfeng Li; Gangling Liao; Li Shen; Melanie Greenway; Shaohui Hu; Jian Zhu; Zhi Xie; Richard F Ambinder; Jiang Qian; Heng Zhu; S Diane Hayward
Journal:  J Virol       Date:  2012-02-29       Impact factor: 5.103

2.  Interleukin 1 receptor-associated kinase 1 (IRAK1) mutation is a common, essential driver for Kaposi sarcoma herpesvirus lymphoma.

Authors:  Dongmei Yang; Wuguo Chen; Jie Xiong; Carly J Sherrod; David H Henry; Dirk P Dittmer
Journal:  Proc Natl Acad Sci U S A       Date:  2014-10-23       Impact factor: 11.205

3.  Tumor suppressor genes FHIT and WWOX are deleted in primary effusion lymphoma (PEL) cell lines.

Authors:  Debasmita Roy; Sang-Hoon Sin; Blossom Damania; Dirk P Dittmer
Journal:  Blood       Date:  2011-06-17       Impact factor: 22.113

4.  Genome wide DNA-profiling of HIV-related B-cell lymphomas.

Authors:  Daniela Capello; Marta Scandurra; Giulia Poretti; Paola M V Rancoita; Michael Mian; Annunziata Gloghini; Clara Deambrogi; Maurizio Martini; Davide Rossi; Timothy C Greiner; Wing C Chan; Maurilio Ponzoni; Santiago M Moreno; Miguel A Piris; Vincenzo Canzonieri; Michele Spina; Umberto Tirelli; Giorgio Inghirami; Andrea Rinaldi; Emanuele Zucca; Riccardo D Favera; Franco Cavalli; Luigi Maria Larocca; Ivo Kwee; Antonino Carbone; Gianluca Gaidano; Francesco Bertoni
Journal:  Br J Haematol       Date:  2009-10-12       Impact factor: 6.998

5.  Gene alteration and precursor and mature microRNA transcription changes contribute to the miRNA signature of primary effusion lymphoma.

Authors:  Andrea J O'Hara; Wolfgang Vahrson; Dirk P Dittmer
Journal:  Blood       Date:  2007-12-13       Impact factor: 22.113

6.  A novel mechanism inducing genome instability in Kaposi's sarcoma-associated herpesvirus infected cells.

Authors:  Brian R Jackson; Marko Noerenberg; Adrian Whitehouse
Journal:  PLoS Pathog       Date:  2014-05-01       Impact factor: 6.823

7.  MicroRNA-34a promotes genomic instability by a broad suppression of genome maintenance mechanisms downstream of the oncogene KSHV-vGPCR.

Authors:  Claudia J Krause; Oliver Popp; Nanthakumar Thirunarayanan; Gunnar Dittmar; Martin Lipp; Gerd Müller
Journal:  Oncotarget       Date:  2016-03-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.